CSE: PHRMOTCQB: PHRRF

Pharmaceutical
3D Printing.
‍

Powered by

Cutaway render of the CORR3CT colon-targeted pill-in-pill tabletRender of a two-layer mucoadhesive oral film on the cheek liningCraftMake Production Plus pharmaceutical 3D printer from Craft Health

Two Oral Delivery Platforms,
Two Peptides (BPC-157 and KPV)

We 3D-print medicines at room temperature, with no heat and no UV, on two delivery platforms. Our initial pipeline is peptides, which usually must be injected: under 1% of a swallowed dose is absorbed. Since October 2026, HHS lets 503A pharmacies compound six peptides; only KPV and BPC-157 are covered for oral use.

Cutaway render of the CORR3CT pill-in-pill tablet showing the inner pill inside the enteric shell

Colon-targeted

The patent-pending pill-in-pill holds through the stomach and releases its dose in the colon, where gut disease is.

SwallowedReleased in the colon
Render of a two-layer mucoadhesive oral film on the cheek lining

Mucoadhesive Oral films

The film sticks to the inside of the cheek. The dose passes through the cheek lining into the bloodstream, bypassing the gut and first-pass liver metabolism.

Placed on the inner cheekSystemic delivery

Our focus: BPC-157 and KPV

Both peptides are being developed on both platforms.

Explore our peptide pipeline

Compounded products are patient-specific prescriptions and are not FDA-approved. No efficacy claims are made. The oral film is in development and its regulatory pathway has not been established. Images are renders.